Copper(II) Lysinate and Pseudoproline Assistance in the Convergent Synthesis of the GLP‑1 Receptor Agonists Liraglutide and Semaglutide

• Published in: Organic process research & development Vol. 25; no. 7; pp. 1598 - 1611
• Main Authors: Guryanov, Ivan, Orlandin, Andrea, De Paola, Ivan, Viola, Angelo, Biondi, Barbara, Badocco, Denis, Formaggio, Fernando, Ricci, Antonio, Cabri, Walter
• Format: Journal Article
• Language: English
• Published: American Chemical Society 16-07-2021
• Subjects: liraglutide; pseudoproline; GLP-1; copper lysinate; solid-phase synthesis; semaglutide
• ISSN: 1083-6160; 1520-586X
• DOI: 10.1021/acs.oprd.1c00021

A growing interest in peptides as active pharmaceutical ingredients (APIs) requires the development of efficient strategies for their preparation. This is particularly challenging in the case of long peptides with a strong tendency for aggregation and folding. Here, we describe the pseudoproline-assisted convergent synthesis of GLP-1 receptor agonist lipopeptides liraglutide and semaglutide, which involves the stepwise condensation of three fragments in the solid phase. The insertion of a pseudoproline residue at the site of fragment coupling prevents aggregation and allows obtaining these peptides with excellent purity and high yield. In addition, for the synthesis of lipidated side chains, we developed a novel approach that involves copper­(II) lysinate intermediates and can be particularly suitable for the industrial preparation of both liraglutide and semaglutide and other peptides with a similar branched structure.